Mucosal Healing Effectiveness and Safety of Anaprazole, a Novel PPI, vs. Rabeprazole in Patients With Duodenal Ulcers: A Randomized Double-Blinded Multicenter Phase II Clinical Trial

Background: Proton pump inhibitors (PPIs) are validated gastric acid suppressors and have been widely used to treat patients with active duodenal ulcers. Although existing PPIs have shown great efficacy, many scientists are still devoted to developing more effective PPIs with better safety profile....

Descripción completa

Detalles Bibliográficos
Autores principales: Shu, Xu, Zhu, Zhenhua, Fu, Yu, Zhang, Zhenyu, Wang, Jiangbin, Li, Xing, He, Shuixiang, Fan, Huizhen, Liu, Side, Zhang, Guoxin, Tang, Jianhua, Huang, Caibin, Du, Qin, Wang, Xiaoyan, Xu, Baohong, Du, Yiqi, Chen, Qikui, Wang, Bangmao, Chen, Ying, Duan, Xianghui, Xie, Yong, Huo, Lijuan, Hou, Xiaohua, Lu, Nonghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317206/
https://www.ncbi.nlm.nih.gov/pubmed/34336894
http://dx.doi.org/10.3389/fmed.2021.690995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317206/
https://www.ncbi.nlm.nih.gov/pubmed/34336894
http://dx.doi.org/10.3389/fmed.2021.690995

Ejemplares similares